John W Smither

ARQT

John W Smither serves as Director at Arcutis Biotherapeutics, Inc. (ARQT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$102.7K

Net Position

Net Seller

$102.7K

Companies Traded

GNLX, ARQT

Active Period

Mar 2021 – Sep 2023

3 total trades

Most Recent

Sell GNLX

Sep 14, 2023 · $18.7K

John W Smither's Insider Trading at Arcutis Biotherapeutics, Inc. (ARQT)

Buys

0 · $0.00

Sells

2 · $84.0K

Total Shares Bought

Total Shares Sold

2,523

ARQT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 10, 2021	Sell	1,750	$32.90	$57.6K	0
Mar 1, 2021	Sell	773	$34.20	$26.4K	0

John W Smither's Insider Trading at Genelux Corporation (GNLX)

Buys

0 · $0.00

Sells

1 · $18.7K

Total Shares Bought

Total Shares Sold

900

GNLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 14, 2023	Sell	900	$20.78	$18.7K	6,920

Related Insiders

Howard G. Welgus

Director

ARQTSell · Apr 3, 2026

Joseph Cappello

VP, Pharmaceutical Development

GNLXSell · Mar 26, 2026

Thomas Zindrick

President and CEO

GNLXSell · Mar 26, 2026

Smalling Ralph

officer: Head of Regulatory

GNLXSell · Mar 26, 2026

Yong Yu

SVP, Clinical Development

GNLXSell · Mar 26, 2026

Latha Vairavan

SVP Chief Financial Officer

ARQTSell · Feb 4, 2026

Todd Watanabe

See Remarks

ARQTSell · Feb 4, 2026

Masaru Matsuda

See Remarks

ARQTSell · Feb 4, 2026

Explore More Insider Trading Data

ARQT Insider Trading Activity

View all insider trades at Arcutis Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity